NovoCure Limited header image

NovoCure Limited

NVCR

Equity

ISIN JE00BYSS4X48 / Valor 29570025

NASDAQ (2026-02-20)

USD 11.36-0.26%

NovoCure Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

NovoCure Limited, founded in 2000 by Prof. Yoram Palti, is an international oncology company specializing in providing patients with a new cancer treatment known as Tumor Treating Fields. This innovative therapy is based on the discovery of the effects of TTFields on cancer cells, which disrupt cancer cell division when applied at specific frequencies. NovoCure's mission is to offer a completely different approach to cancer therapy, offering hope to patients seeking alternative treatment options.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-47.5%1Y

-86.6%3Y

-94.0%5Y

Performance

65.1%1Y

80.1%3Y

79.1%5Y

Volatility

1272 M

Market cap (USD)

1,280,971

Daily traded volume (Shares)

30.63 / 29.83

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Draegerwerk AG & Co. KGaA

Draegerwerk AG & Co. KGaA Valor: 330446

Annual Return

-50%0%+50%

Risk level

110

2.29%EUR 94.00

AMN Healthcare Services Inc

AMN Healthcare Services Inc Valor: 1269241

Annual Return

-50%0%+50%

Risk level

110

11.81%USD 19.32

Getinge AB

Getinge AB Valor: 84926

Annual Return

-50%0%+50%

Risk level

110

1.60%SEK 203.60

Icon PLC

Icon PLC Valor: 1017575

Annual Return

-50%0%+50%

Risk level

110

1.31%USD 99.70

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

1.06%EUR 15.26

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

1.28%SEK 285.70

Curatis Holding Ltd

Curatis Holding Ltd Valor: 133078097

Annual Return

-50%0%+50%

Risk level

110

0.58%CHF 17.40

Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc Valor: 912793

Annual Return

-50%0%+50%

Risk level

110

-0.22%USD 271.30

Shield Therapeutics PLC

Shield Therapeutics PLC Valor: 29778101

Annual Return

-50%0%+50%

Risk level

110

-1.03%GBP 0.097

Sanofi SA

Sanofi SA Valor: 1447201

Annual Return

-50%0%+50%

Risk level

110

-1.31%USD 46.76

SIX

FactSet

Clearbit

Logos provided by Clearbit